161 related articles for article (PubMed ID: 37858622)
1. Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme.
Kumari S; Gupta R; Ambasta RK; Kumar P
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188999. PubMed ID: 37858622
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment.
Kumari S; Kumar P
Front Cell Dev Biol; 2023; 11():1236271. PubMed ID: 37538397
[TBL] [Abstract][Full Text] [Related]
3. Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy.
Kumari S; Gupta R; Ambasta RK; Kumar P
Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188913. PubMed ID: 37182666
[TBL] [Abstract][Full Text] [Related]
4. Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma.
Jayaram S; Gupta MK; Raju R; Gautam P; Sirdeshmukh R
OMICS; 2016 Dec; 20(12):736-746. PubMed ID: 27930095
[TBL] [Abstract][Full Text] [Related]
5. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
6. Targeting post-translational histone modifying enzymes in glioblastoma.
Kunadis E; Lakiotaki E; Korkolopoulou P; Piperi C
Pharmacol Ther; 2021 Apr; 220():107721. PubMed ID: 33144118
[TBL] [Abstract][Full Text] [Related]
7. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
[TBL] [Abstract][Full Text] [Related]
8. Computational refinement of post-translational modifications predicted from tandem mass spectrometry.
Chung C; Liu J; Emili A; Frey BJ
Bioinformatics; 2011 Mar; 27(6):797-806. PubMed ID: 21258065
[TBL] [Abstract][Full Text] [Related]
9. Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples.
Petushkova NA; Zgoda VG; Pyatnitskiy MA; Larina OV; Teryaeva NB; Potapov AA; Lisitsa AV
PLoS One; 2017; 12(5):e0177427. PubMed ID: 28493947
[TBL] [Abstract][Full Text] [Related]
10. Small Tweaks, Major Changes: Post-Translational Modifications That Occur within M2 Macrophages in the Tumor Microenvironment.
Zheng S; Liang Y; Tan Y; Li L; Liu Q; Liu T; Lu X
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428622
[TBL] [Abstract][Full Text] [Related]
11. Novel Post-Translational Modifications and Molecular Substrates in Glioma Identified by Bioinformatics.
Rex DAB; Arun Kumar ST; Rai AB; Kotimoole CN; Modi PK; Prasad TSK
OMICS; 2021 Jul; 25(7):463-473. PubMed ID: 34227895
[TBL] [Abstract][Full Text] [Related]
12. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
Liu Y; Li X; Zhang Y; Wang H; Rong X; Peng J; He L; Peng Y
Oncogene; 2019 Dec; 38(49):7399-7415. PubMed ID: 31427735
[TBL] [Abstract][Full Text] [Related]
13. Towards developing biomarkers for glioblastoma multiforme: a proteomics view.
Jayaram S; Gupta MK; Polisetty RV; Cho WC; Sirdeshmukh R
Expert Rev Proteomics; 2014 Oct; 11(5):621-39. PubMed ID: 25115191
[TBL] [Abstract][Full Text] [Related]
14. Advances in post-translational modifications of proteins and cancer immunotherapy.
Li Y; Zhang R; Hei H
Front Immunol; 2023; 14():1229397. PubMed ID: 37675097
[TBL] [Abstract][Full Text] [Related]
15. Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.
Li W; Li F; Zhang X; Lin HK; Xu C
Signal Transduct Target Ther; 2021 Dec; 6(1):422. PubMed ID: 34924561
[TBL] [Abstract][Full Text] [Related]
16. Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment.
Khodadadi H; Salles ÉL; Alptekin A; Mehrabian D; Rutkowski M; Arbab AS; Yeudall WA; Yu JC; Morgan JC; Hess DC; Vaibhav K; Dhandapani KM; Baban B
Cannabis Cannabinoid Res; 2023 Oct; 8(5):824-834. PubMed ID: 34918964
[No Abstract] [Full Text] [Related]
17. Pathological implication of protein post-translational modifications in cancer.
Pan S; Chen R
Mol Aspects Med; 2022 Aug; 86():101097. PubMed ID: 35400524
[TBL] [Abstract][Full Text] [Related]
18. Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.
Papavassiliou KA; Papavassiliou AG
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188667. PubMed ID: 34894431
[TBL] [Abstract][Full Text] [Related]
19.
Shi Y; Jiang J; Cui Y; Chen Y; Dong T; An H; Liu P
DNA Cell Biol; 2021 Jan; 40(1):93-100. PubMed ID: 33181035
[TBL] [Abstract][Full Text] [Related]
20. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
